Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G94435QH
Summary
- GlyTouCan ID
-
G94435QH
- IUPAC Condensed
- Fuc(a1-2)Gal(b1-3)GalNAc(a1-
- Motifs
- H antigen (type 3)
- Subsumption Level
- Fully-defined saccharide
- Monoisotopic Mass
- 529.2
G96057TO
G35778AN
3D Structures
- GlycoNAVI
- G94435QH
- GlycoShape
- G94435QH
- GLYCAM
- LFucpa1-2DGalpb1-3DGalpNAca1-OH
Organisms
| Organisms | Evidence |
|---|---|
| Mus musculus (house mouse) | |
| Homo sapiens (human) | |
| Rattus norvegicus (Norway rat) | |
| Sus scrofa (pig) |
Taxonomic Hierarchy
GlycoGene Database (GGDB)
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| ST6GALNAC1 | CMP-Neu5Ac |
G94435QH
|
O-glycan Synthesis |
G47180UC
|
O-glycan Synthesis |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| ST6GALNAC1 | CMP-Neu5Ac |
G94435QH
|
O-glycan Synthesis |
G47180UC
|
O-glycan Synthesis | |
| FUT2 | GDP-Fuc |
G00031MO
|
O-glycan Synthesis |
G94435QH
|
O-glycan Synthesis | |
| B(ABO) | UDP-Gal |
G94435QH
|
O-glycan Synthesis |
G88313DY
|
O-glycan Synthesis | |
| A(ABO) | UDP-GalNAc |
G94435QH
|
O-glycan Synthesis |
G99315PE
|
O-glycan Synthesis |
Core Protein
GlycoEpitope
- Epitope ID
- EP0253
- Epitope Name
- Blood Group H Type 3
Sequence Descriptors
- GlycoCT
-
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl 3b:b-dgal-HEX-1:5 4b:a-lgal-HEX-1:5|6:d LIN 1:1d(2+1)2n 2:1o(3+1)3d 3:3o(2+1)4d
- WURCS
- WURCS=2.0/3,3,2/[a2112h-1a_1-5_2*NCC/3=O][a2112h-1b_1-5][a1221m-1a_1-5]/1-2-3/a3-b1_b2-c1
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 32841605 | Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor | Zhao P | 2020 Oct 07 |
|
| 32236654 | Colorectal cancer cell lines show striking diversity of their O-glycome reflecting the cellular differentiation phenotype | Madunic K | 2020 Mar 31 |
|
| 17087964 | O-Methylated glycans from Toxocara are specific targets for antibody binding in human and animal infections | Schabussova I | 2007 Jan |
|
| 12164788 | Intestinal mucins from cystic fibrosis mice show increased fucosylation due to an induced Fucalpha1-2 glycosyltransferase | Thomsson KA | 2002 Nov 01 |
|
| 11445551 | In vivo glycosylation of mucin tandem repeats | Silverman HS | 2001 Jun |
|
| 8445257 | Immunochemical characterization of anti-H monoclonal antibodies obtained from a mouse immunized with human saliva | Nakajima T | 1993 Feb 26 |
|
| 8384526 | An improved approach to the analysis of the structure of small oligosaccharides of glycoproteins: application to the O-linked oligosaccharides from human glycophorin A | Krotkiewski H | 1993 Feb 01 |
|
| 1609521 | Serological and Chemical Specificities of Twelve Monoclonal Anti‐Lea and Anti‐Leb Antibodies | Good AH | 1992 |
|
| 1627559 | The broad diversity of neutral and sialylated oligosaccharides derived from human salivary mucins | Klein A | 1992 Jul 7 |
|
| 3345749 | Primary structure of neutral oligosaccharides derived from respiratory-mucus glycoproteins of a patient suffering from bronchiectasis, determined by combination of 500-MHz 1H-NMR spectroscopy and quantitative sugar analysis. 1. Structure of 16 oligosaccharides having the Gal beta(1----3)GalNAc-ol core (type 1) or the Gal beta(1----3)[GlcNAc beta(1----6)]GalNac-ol core (type 2) | Klein A | 1988 Feb 1 |
|
